Comparing the soluble urokinase-type plasminogen activator receptor (suPAR) levels between individuals with subjective cognitive decline and mild cognitive impairment

被引:0
|
作者
Batun, G. Cetiner [1 ]
Gultekin, G. [1 ]
Yuruyen, M. [2 ]
Yavuzer, H. [3 ]
Armutcu, F. [4 ]
Emul, M. [1 ]
Kocabasoglu, N. [1 ]
机构
[1] Istanbul Univ, Med Sch Cerrahpasa, Psychiat, Istanbul, Turkey
[2] Istanbul Univ, Med Sch Cerrahpasa, Dept Geriatr, Istanbul, Turkey
[3] Istanbul Univ, Med Sch Cerrahpasa, Geriatr, Istanbul, Turkey
[4] Istanbul Univ, Med Sch Cerrahpasa, Biochem, Istanbul, Turkey
关键词
CANCER;
D O I
10.1016/S0924-977X(16)31734-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.5.a.004
引用
收藏
页码:S637 / S638
页数:2
相关论文
共 50 条
  • [41] Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Biomarker Associated with Left Ventricular Hypertrophy in the Elderly, Specifically in Women
    Wlazel, Rafal Nikodem
    Guligowska, Agnieszka
    Chrzastek, Zuzanna
    Kostka, Tomasz
    Jegier, Anna
    Szadkowska, Iwona
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
  • [42] Soluble urokinase-type plasminogen activator receptor (suPAR) as new biomarker of the prosthetic joint infection: Correlation with inflammatory cytokines
    Galliera, Emanuela
    Drago, Lorenzo
    Marazzi, Monica Gioia
    Romano, Carlo
    Vassena, Christian
    Romanelli, Massimiliano M. Corsi
    CLINICA CHIMICA ACTA, 2015, 441 : 23 - 28
  • [43] The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine
    Jan Simon Scharrenberg
    Ayla Yagdiran
    Julia Brinkmann
    Maik Brune
    Jan Siewe
    Norma Jung
    Esther Mahabir
    Journal of Orthopaedic Surgery and Research, 14
  • [44] The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine
    Scharrenberg, Jan Simon
    Yagdiran, Ayla
    Brinkmann, Julia
    Brune, Maik
    Siewe, Jan
    Jung, Norma
    Mahabir, Esther
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2019, 14 (01)
  • [45] Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinsons disease (P1-1.Virtual)
    Witek, Natalie
    Joyce, Jessica
    Patel, Roshni
    Hawkins, Jacob
    Liu, Yuanqing
    Ouyang, Bichun
    Borgia, Jeffrey
    Jochen, Reiser
    Hall, Deborah
    NEUROLOGY, 2022, 98 (18)
  • [46] Soluble urokinase-type plasminogen activator receptor (suPAR) in patients with acute pancreatitis (AP) - Progress in prediction of AP severity
    Lipinski, Michal
    Rydzewska-Rosolowska, Alicja
    Rydzewski, Andrzej
    Cicha, Malgorzata
    Rydzewska, Grazyna
    PANCREATOLOGY, 2017, 17 (01) : 24 - 29
  • [47] Soluble urokinase type plasminogen activator receptor (suPAR) and mortality in acute pulmonary embolism
    Oblitas, Crhistian-Mario
    Lopez-Rubio, Marina
    Lago-Rodriguez, Marta-Olimpia
    Galeano-Valle, Francisco
    Garcia-Gamiz, Mercedes
    Zamora-Trillo, Angielys
    Walther, Luis-Antonio Alvarez-Sala
    Demelo-Rodriguez, Pablo
    MEDICINA CLINICA, 2024, 163 (06): : 281 - 285
  • [48] Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individuals
    Chew-Harris, Janice
    Appleby, Sarah
    Richards, A. Mark
    Troughton, Richard W.
    Pemberton, Christopher J.
    CLINICAL BIOCHEMISTRY, 2019, 69 : 36 - 44
  • [49] Tissue urokinase-type plasminogen activator receptor levels in breast cancer
    Gong, SJ
    Rha, SY
    Chung, HC
    Yoo, NC
    Roh, JK
    Yang, WI
    Lee, KS
    Min, JS
    Kim, BS
    Chung, HC
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2000, 6 (03) : 301 - 305
  • [50] Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea
    Bocskei, Renata Marietta
    Meszaros, Martina
    Tarnoki, Adam Domonkos
    Tarnoki, David Laszlo
    Kunos, Laszlo
    Lazar, Zsofia
    Bikov, Andras
    MEDICINA-LITHUANIA, 2020, 56 (02):